Works matching DE "NOVO Nordisk A/S"
Results: 156
Domestic Institutions and Market Pressures as Drivers of Corporate Social Responsibility: Company Initiatives in Denmark and the UK.
- Published in:
- Political Studies, 2015, v. 63, n. 1, p. 181, doi. 10.1111/1467-9248.12092
- By:
- Publication type:
- Article
An overview of turoctocog alfa pegol (N8‐GP; ESPEROCT<sup>®</sup>) assay performance: Implications for postadministration monitoring.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 156, doi. 10.1111/hae.13897
- By:
- Publication type:
- Article
International comparative field study of N8 evaluating factor VIII assay performance.
- Published in:
- Haemophilia, 2011, v. 17, n. 4, p. 695, doi. 10.1111/j.1365-2516.2010.02481.x
- By:
- Publication type:
- Article
The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
- Published in:
- Haemophilia, 2009, v. 15, n. 3, p. 733, doi. 10.1111/j.1365-2516.2009.01980.x
- By:
- Publication type:
- Article
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 8, p. 751, doi. 10.1007/s40273-022-01140-y
- By:
- Publication type:
- Article
Race towards an insulin pill.
- Published in:
- African Journal of Diabetes Medicine, 2013, v. 21, n. 2, p. 28
- Publication type:
- Article
Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5): A Randomized Trial.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 11, p. 1476, doi. 10.7326/M23-1288
- By:
- Publication type:
- Article
Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of N8-GP Activity Using a One-Stage Clotting Assay: A Single-Center Experience.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 5, p. 504, doi. 10.1159/000503377
- By:
- Publication type:
- Article
Novo awaits green light for diabetes drug.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 8, p. 682, doi. 10.1038/nbt0809-682c
- By:
- Publication type:
- Article
Inhaled insulin's last gasp?
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 5, p. 479, doi. 10.1038/nbt0508-479
- By:
- Publication type:
- Article
Another inhaled insulin casualty.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 3, p. 255, doi. 10.1038/nbt0308-255a
- By:
- Publication type:
- Article
First in class stimulates natural killer cells.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 6, p. 597, doi. 10.1038/nbt0606-597
- By:
- Publication type:
- Article
Novo Nordisk Haemophilia Foundation website.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 649, doi. 10.1111/j.1365-2141.2006.06149.x
- Publication type:
- Article
New drugs and dosage forms.
- Published in:
- 2008
- Publication type:
- Product Review
FDA Issues CRL to Novo Nordisk for Once-Weekly Insulin Icodec.
- Published in:
- Patient Care (Online), 2024, p. 2
- By:
- Publication type:
- Article
Biphasic Insulin Aspart in Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2007, v. 27, n. 5, p. 299, doi. 10.2165/00044011-200727050-00002
- By:
- Publication type:
- Article
Staff Attitudes to Talking Openly About Ethical Dilemmas: The Role of Business Ethics Conceptions and Trust.
- Published in:
- 2011
- By:
- Publication type:
- Report
Liraglutide treatment attenuates dysfunction-related changes in the cardiac and cerebral microvasculature in streptozotocin-induced diabetic rats.
- Published in:
- Cardiovascular Research, 2022, v. 118, p. 1, doi. 10.1093/cvr/cvac066.234
- By:
- Publication type:
- Article
New Products.
- Published in:
- 2007
- Publication type:
- Product Review
EFSD, JDRF and Novo Nordisk announce 8 grants of Euro 100,000.
- Published in:
- Diabetologia, 2006, v. 49, n. 2, p. 424, doi. 10.1007/s00125-005-0113-3
- Publication type:
- Article
Thrombosis: Balancing act.
- Published in:
- Nature, 2014, v. 515, n. s7528, p. S168, doi. 10.1038/515S168a
- By:
- Publication type:
- Article
Oral GLP1 analogue rounds Phase II corner.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 4, p. 227, doi. 10.1038/nrd4607
- By:
- Publication type:
- Article
Mads Krogsgaard Thomsen.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 2, p. 96, doi. 10.1038/nrd4238
- Publication type:
- Article
Focus on 2009: A year of novel pharmacologic agents in review.
- Published in:
- Formulary, 2009, v. 44, n. 11, p. 336
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2007, v. 42, n. 11, p. 627
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2005, v. 40, n. 10, p. 322
- Publication type:
- Article
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 10, p. 2559, doi. 10.3390/diagnostics12102559
- By:
- Publication type:
- Article
Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal–bolus insulin in UK clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3841, doi. 10.1111/dom.15278
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 1, p. 97, doi. 10.1111/j.1463-1326.2011.01541.x
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 3, p. 285, doi. 10.1111/j.1463-1326.2011.01360.x
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 7, p. 729, doi. 10.1111/j.1463-1326.2009.01083.x
- By:
- Publication type:
- Article
GENERIC DRUGS POST NOVO NORDISK.
- Published in:
- Entrepreneurial Business Law Journal, 2012, v. 7, n. 1, p. 193
- By:
- Publication type:
- Article
Novo Nordisk Completes Expansion of Enzyme Plant.
- Published in:
- Textile Chemist & Colorist, 1994, v. 26, n. 6, p. 2
- Publication type:
- Article
News.
- Published in:
- Textile Chemist & Colorist, 1994, v. 26, n. 6, p. 3
- Publication type:
- Article
Novo Nordisk Breaks Ground For $100 Million Expansion.
- Published in:
- Textile Chemist & Colorist, 1992, v. 24, n. 6, p. 12
- Publication type:
- Article
Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program.
- Published in:
- International Journal of Pediatric Endocrinology, 2020, v. 2020, n. 1, p. N.PAG, doi. 10.1186/s13633-020-00089-z
- By:
- Publication type:
- Article
Diabetes UK.
- Published in:
- Podiatry Review, 2009, v. 66, n. 5, p. 26
- Publication type:
- Article
Living with growth hormone treatment.
- Published in:
- 2010
- By:
- Publication type:
- Book Review
Fluor to build US diabetes medicine plant.
- Published in:
- TCE: The Chemical Engineer, 2017, n. 908, p. 14
- Publication type:
- Article
Novo Nordisk plans Tianjin insulin.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 810/811, p. 14
- Publication type:
- Article
Comparison of the Dosing Accuracy of Two Insulin Injection Devices.
- Published in:
- Diabetes, 2007, v. 56, p. A535
- By:
- Publication type:
- Article
Comparative Assessment of NovoPen® 4, A New Insulin Pen System, Among Present NovoPen® 3 Users.
- Published in:
- Diabetes, 2007, v. 56, p. A532
- By:
- Publication type:
- Article
Implementation and comparison of two text mining methods with a standard pharmacovigilance method for signal detection of medication errors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
El envejecimiento como megatendencia.
- Published in:
- Hacer Empresa, 2022, n. 119, p. 46
- By:
- Publication type:
- Article
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).
- Published in:
- Journal of Blood Medicine, 2019, v. 11, p. 335, doi. 10.2147/JBM.S219573
- By:
- Publication type:
- Article
The Diabetes Attitudes, Wishes and Needs (DAWN) Study.
- Published in:
- Clinical Diabetes, 2006, v. 24, n. 4, p. 154, doi. 10.2337/diaclin.24.4.154
- By:
- Publication type:
- Article
Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Alliances.
- Published in:
- Applied Clinical Trials, 2008, v. 17, n. 8, p. 64
- Publication type:
- Article
Subject Recruitment By Far Biggest Clinical Trial Concern.
- Published in:
- Applied Clinical Trials, 2004, v. 13, n. 9, p. 16
- Publication type:
- Article